Mast Cell–Microglia Crosstalk Drives Aberrant Synaptic Pruning Through PAR‐2/MAPK/NF‐κB Signaling in Neonatal Hypoxic–Ischemic Encephalopathy Yanping Yang, Dingliang Cai, Jingwen Yu, Yixiao Zhu, Yongxin Huang, Yubing Lin, Chengqian Teng, Jianjie Wei, Ying Lin, Dongsheng Dai, Fushan Xue, Andi Chen, Xiaochun Zheng, Xiaohui Chen Abstract ABSTRACTAimsNeonatal hypoxic–ischemic encephalopathy (HIE) causes severe neurodevelopmental impairment, but the upstream immune mechanisms that initiate this process remain unclear. We investigated whether mast cell (MC)‐derived tryptase contributes to aberrant microglia‐mediated synaptic pruning through PAR‐2/MAPK/NF‐κB signaling after neonatal hypoxic–ischemic (HI) injury.MethodsA postnatal Day‐7 rat HI model was established using the Rice‐Vannucci method. MC abundance, c‐Kit and tryptase expression, PAR‐2/MAPK/NF‐κB signaling, and synaptic integrity were assessed using histological, immunofluorescence, biochemical, ultrastructural, and three‐dimensional (3D) reconstruction analyses. Microglia‐targeted F2rl1 silencing and pharmacological inhibition with FSLLRY‐NH2 or APC366 were used to examine PAR‐2 and tryptase‐related signaling. Complementary oxygen–glucose deprivation/reperfusion (OGD/R) experiments were performed in BV‐2 microglia. Cognitive outcomes were assessed using the Morris water maze and Y maze.ResultsHI increased hippocampal MC abundance and tryptase expression, and these changes were associated with acute neurological deficits. HI insult also increased complement associated synaptic labeling, PAR‐2/MAPK/NF‐κB signaling, CD68 expression, and engulfment of PSD95 positive synaptic material. Microglia‐targeted F2rl1 silencing attenuated pathway activation and synaptic engulfment. FSLLRY‐NH2 and APC366 similarly reduced HI associated signaling and microglial synaptic engulfment, while APC366 preserved dendritic spine density and synaptic ultrastructure and improved long‐term spatial learning and memory. In BV‐2 microglial cells, exogenous tryptase enhanced OGD/R associated CD68 expression and MAPK/NF‐κB phosphorylation, which were attenuated by F‐NH2.ConclusionMC‐derived tryptase is an upstream contributor to pathological microglial synaptic pruning and cognitive impairment after neonatal HI, potentially involving the PAR‐2/MAPK/NF‐κB axis. Following neonatal hypoxic–ischemic injury, hippocampal mast cell degranulation releases tryptase, which activates microglial PAR‐2 receptors to trigger p38 MAPK/NF‐κB signaling and drive aberrant synaptic engulfment. This pathological mast cell–microglia crosstalk leads to progressive synaptic loss and long‐term cognitive impairment. Pharmacological blockade of tryptase or PAR‐2 suppresses aberrant microglial pruning activity, preserves synaptic integrity, and rescues spatial memory deficits.[CNS-32-e71189-g003.webp] Introduction Neonatal hypoxic–ischemic encephalopathy (HIE) is a brain injury disease resulting from the disruption of cerebral blood flow and oxygen supply during birth. It is one of the most common acquired brain injuries in newborns and remains a leading cause of long‐term neurodevelopmental impairment []. However, the cellular and molecular mechanisms underlying neural injury in HIE have not been fully elucidated. Most previous research has primarily focused on the interactions among three types of brain cells: activated microglia, reactive astrocytes, and injured or apoptotic neurons [, , ]. Although potential mechanisms underlying how glial cells contribute to neuroinflammatory cascades and neuronal damage have been identified, the upstream role of other immune cell populations in regulating microglial activation and subsequent neuronal injury remains poorly understood and warrants further investigation. MC are multifunctional immune cells that play a pivotal role in regulating and monitoring the body's inflammatory responses [, ]. In the central nervous system (CNS), they act as early responders to brain injury and can trigger neuroinflammatory cascades before resident glial cells are activated [, ]. MC activation has been implicated in several neurological disorders and is thought to amplify neuroinflammation and secondary neuronal damage through interactions with glial and vascular compartments [, , , , ]. Previous studies have shown that MC activation occurs at an early stage after HI and is accompanied by increased MC number and inflammatory mediator release in rats. Recent evidence further suggests that hippocampal MC may contribute to BBB permeability and immune cell infiltration after brain injury in mice [, ]. However, it remains unclear whether mast cell activation interacts with microglia and thereby contributes to the initiation and progression of brain injury in HIE. Evidence suggests that MC‐derived mediators, including histamine, serotonin, and tryptase, can modulate microglial function, suggesting that microglia may represent an important downstream effector of MC signaling [, ]. Microglia are key regulators of synaptic pruning during CNS development and selectively engulf redundant synapses through molecular cues such as complement proteins C3 and C1q [, ]. The fractalkine receptor C‐X3‐C motif chemokine receptor 1 (CX3CR1) contributes to microglia–neuron communication, adhesion, and chemotaxis, whereas CD68 is associated with lysosomal and phagocytic activity [, ]. Under pathological conditions, dysregulated microglia‐mediated synaptic pruning can lead to excessive synapse loss and neurological dysfunction [, ]. However, it remains unclear whether HI disrupts microglia‐mediated synaptic pruning during the early postnatal period, a critical developmental window when this process is highly active. In addition, the upstream molecular signals and cellular mediators that drive the shift from physiological to pathological synaptic pruning have yet to be fully elucidated. Recent studies have demonstrated that tryptase derived from MC can cleave and activate protease‐activated receptor‐2 (PAR‐2) on microglia, which may trigger mitogen‐activated protein kinase (MAPK) phosphorylation and modulate microglial function through the NF‐κB signaling pathway [, , ]. These findings suggest that PAR‐2 may contribute to MC‐microglia communication. Consistent with this possibility, PAR‐2 expression is upregulated in microglia in both the HI model and the oxygen–glucose deprivation/reperfusion (OGD/R) model, suggesting its potential involvement in HIE pathophysiology []. Additional evidence from other neuroinflammatory models identifies PAR‐2 as an important regulator of glia‐driven CNS pathology []. However, whether MC‐derived tryptase engages microglial PAR‐2 to excessive synaptic pruning via the PAR‐2/MAPK/NF‐κB axis in neonatal rats remains to be determined. We hypothesized that HI insult‐induced tryptase activates microglial PAR‐2/MAPK/NF‐κB signaling and promotes synaptic damage and cognitive dysfunction through excessive PSD95 engulfment. Materials and Methods Animals and Experimental Design All experimental procedures were performed using postnatal Day 7 (P7) male and female Sprague–Dawley rats subjected to the Rice–Vannucci hypoxic–ischemic (HI) model. Animals were randomized within litters, and all feasible analyses were conducted under coded, blinded conditions to minimize experimental bias. Detailed descriptions of the experimental design, group allocation, and ethical protocols are provided in and Methods . Histological Staining and 2,3,5‐Triphenyltetrazolium Chloride (TTC) Staining Cerebral injury and mast cell‐related signaling alterations were evaluated via multiple staining approaches, including H&E, TTC, Nissl, and TUNEL staining, as well as c‐Kit/tryptase dual labeling. Detailed operational procedures are specified in and Methods and Table . RNA Sequencing and Library Construction Bulk RNA sequencing (RNA‐seq) of hippocampal tissues was performed following HI injury, with full methodological details provided in and Methods . Behavioral Assessments of Acute Neurological Impairment Acute neurological dysfunction was evaluated at 24 h post‐HI injury. Relevant experimental methods are documented in and Methods . Intranasal Drug Administration F‐NH2 (a selective PAR2 antagonist) or APC366 (a specific mast cell tryptase inhibitor) was delivered via intranasal administration after HI surgery or sham operation, with matched vehicle groups set as controls. Detailed administration protocols are available in and Methods . Microglia‐Targeted F2rl1 Silencing For microglia‐targeted F2rl1 knockdown, AAV9‐CX3CR1‐shF2rl1 or control shRNA was stereotaxically injected into the rat hippocampus on P1 prior to HI injury. Detailed procedures are described in and Methods [, ]. BV‐2 Cell OGD/R and Pharmacological Treatments BV‐2 microglial cells were subjected to oxygen–glucose deprivation/reoxygenation (OGD/R) injury, followed by treatment with vehicle, F‐NH2, tryptase, or their combination. Detailed cell experiments and pharmacological intervention protocols are provided in and Methods . Western Blotting Western blotting was performed to detect the expression of target proteins. Protein expression was quantified with β‐actin as the internal reference, and phosphorylated protein levels were normalized to their respective total protein levels. Detailed experimental procedures are listed in and Methods and Table . Immunofluorescence Staining Immunofluorescence staining, single‐channel quantitative analysis, ImageJ‐based surface visualization, and Z‐stack three‐dimensional (3D) reconstruction were conducted as previously described in and Methods and Table . Transmission Electron Microscopy Transmission electron microscopy (TEM) was utilized to observe and analyze the ultrastructural characteristics of hippocampal synapses. Relevant methods are provided in and Methods . Golgi Staining Golgi staining was applied to assess neuronal dendritic morphology and spine density in hippocampal tissues. Detailed protocols are shown in and Methods . Behavioral Tests of Cognitive Function Cognitive function was evaluated via Y‐maze and Morris water maze tests starting at P30 (23 days after HI injury). Specific testing procedures are described in and Methods . Statistical Analysis Statistical analyses were performed using SPSS 22.0 software (SPSS Inc., USA). Normality was assessed using the Shapiro–Wilk test, and homogeneity of variance was evaluated using Levene's test. Normally distributed data are presented as mean ± standard error of the mean (SEM). A p value < 0.05 was considered statistically significant. Detailed statistical methods are provided in and Methods . Results Mast Cell Activation and Tryptase Expression Were Associated With Early Behavioral Deficits After HI Insult We first validated successful establishment of the Rice‐Vannucci neonatal HI model. TTC staining demonstrated prominent infarction within the ipsilateral hemisphere in HI injured animals relative to sham controls (Figure ). TUNEL staining revealed enhanced neuronal apoptosis, and Nissl staining showed evident neuronal loss in the hippocampus (Figure ). We then investigated hippocampal MC activation and tryptase production after HI. Compared with sham rats, HI animals exhibited expanded c‐Kit‐ and tryptase‐positive signals, greater numbers of morphologically identifiable mast cells, and increased cKit+/tryptase+ double‐positive cells in the hippocampus (Figure ). Western blotting further confirmed sustained upregulation of tryptase within 24 h post‐HI (Figure ). At 24 h after injury, HI rats displayed acute neurological impairment, reflected by prolonged latencies for the righting‐reflex, cliff‐avoidance, and negative‐geotaxis tests, alongside shortened forelimb‐suspension duration (Figure ). Correlation analyses demonstrated that hippocampal mast‐cell abundance and tryptase levels positively correlated with these response latencies and negatively correlated with forelimb‐suspension time (Figure ), linking mast‐cell activation and tryptase expression to early neurological dysfunction. To dissect the downstream molecular signatures accompanying mast‐cell‐driven pathology, we performed bulk RNA‐seq on post‐HI hippocampal tissue. Volcano‐plot analysis identified 208 significantly up‐regulated and 180 down‐regulated genes in HI versus sham rats (Figure ). A targeted heatmap illustrated coordinated transcriptional alterations, including complement‐related genes (C1qa, C1qb, C1qc, C3), mast‐cell‐associated proteases and receptors (Cma1, Tpsab1, Tpsb2, Cpa3, Kit, Fcer1g), pro‐inflammatory mediators (Il1b, Il6), the “don't‐eat‐me” signal Cd47, phagolysosomal activity, and microglia–neuron communication related transcripts (Cd68, Cx3cr1), and CSF1R‐signaling ligands (Csf1, Il34) (Figure ). Gene Ontology enrichment highlighted complement receptor activity, complement activation, and synaptic pruning related biological processes (Figure ), while KEGG pathway analysis revealed enrichment for complement cascades, cytokine‐cytokine receptor interactions, and MAPK signaling (Figure ). Collectively, these results show that HI triggers mast‐cell activation and tryptase elevation associated with early neurological deficits, accompanied by broad transcriptomic reprogramming encompassing complement driven innate immunity and MAPK mediated neuroinflammation. HI Insult Promotes Abnormal Microglia Associated Synaptic Pruning To determine whether HI injury is associated with aberrant synaptic pruning involving complement and chemokine signaling, we examined key molecular and cellular features of this process. Complement proteins C1q and C3 serve as “eat‐me” signals that label synapses for elimination by microglia []. CX3CR1 is a fractalkine receptor involved in microglia–neuron communication, adhesion, and chemotaxis through neuronal CX3CL1, whereas CD68 is a lysosomal marker commonly used to identify microglia with a phagocytosis‐associated phenotype [, ]. We found that compared with sham controls, HI injured rats displayed markedly higher numbers of C1q+/NeuN+ and C3+/NeuN+ cells (Figure ), accompanied by significantly elevated relative fluorescence intensities of C1q and C3 (Figure ). For microglial phagocytic markers, HI rats showed increased counts of Iba1+/CD68+ and Iba1+/CX3CR1+ microglia (Figure ), along with enhanced relative fluorescence intensities of CD68 and CX3CR1 (Figure ). Elevated Iba1 colocalized CX3CR1 signal reflected upregulated microglial CX3CR1 expression/localization, implying perturbed CX3CL1‐CX3CR1 signaling. In parallel, increased CD68 expression denoted a lysosome‐enriched phagocytic phenotype. Collectively, these data demonstrate augmented complement deposition and microglial phenotypic shifts linked to synaptic pruning after HI. To obtain direct evidence for microglia‐dependent synaptic engulfment, we performed 3D reconstruction of immunofluorescence labeled Iba1+ microglia and the postsynaptic marker PSD95 using Imaris software. Quantitative 3D analysis revealed a significantly increased volume of PSD95 signal internalized within Iba1+ microglia in HI rats compared with sham rats, providing direct morphological evidence of enhanced engulfment of postsynaptic components (Figure ). Furthermore, ultrastructural analysis showed that HI injury reduced the number of presynaptic vesicles and shortened the postsynaptic density compared with the sham group (Figure ). Taken together, these results suggest that HI provokes pathological microglia‐mediated synaptic pruning, manifested by robust complement deposition, a CD68 positive phagocytic microglial state, increased postsynaptic engulfment, and disrupted synaptic ultrastructure. PAR‐2/MAPK/NF‐κB Signaling Contributes to Microglia Mediated Synaptic Pruning Accumulating evidence indicates that PAR‐2 acts as a critical signaling bridge linking mast cell activation to microglial inflammatory responses. Given the robust upregulation of mast cell‐derived tryptase following HI injury in our model, we next examined the cellular distribution and expression changes of PAR‐2 in hippocampal neurons, astrocytes, and microglia. Single‐channel fluorescence quantification demonstrated a significant elevation in overall PAR‐2 immunoreactivity in the HI group relative to sham controls (Figure ). Notably, the colocalization levels of PAR‐2 with NeuN+ neurons and GFAP+ astrocytes remained unaltered after HI injury (Figure ). In contrast, both PAR‐2 fluorescence intensity and the abundance of PAR‐2+/Iba1+ double‐positive microglia were markedly increased in HI rats (Figure ). These results demonstrate that HI specifically induces PAR‐2 upregulation predominantly in microglia, rather than in neurons or astrocytes. We further characterized the activation status of the downstream MAPK/NF‐κB signaling cascade. Western blot analysis revealed significantly elevated PAR‐2 protein expression, as well as increased phosphorylation ratios of p38 MAPK and NF‐κB p65 after HI injury. These signaling alterations peaked at 24 h post‐insult, while the total protein levels of p38 MAPK and NF‐κB p65 remained stable across groups (Figure ). The temporal activation pattern of PAR‐2 and its downstream signaling cascade was consistent with the dynamic elevation of mast cell tryptase, implying a potential regulatory axis of mast cell tryptase/PAR‐2/MAPK/NF‐κB in HI brain injury. To further validate the functional role of PAR‐2 signaling in mediating HI triggered microglial activation and pathological synaptic pruning, we pharmacologically inhibited PAR‐2 activity via pretreatment with the PAR‐2 antagonist F‐NH2 prior to HI modeling. Compared with the vehicle treated HI group, F‐NH2 treatment significantly reduced PAR‐2 fluorescence intensity and decreased the number of PAR‐2+/Iba1+ microglia (Figure ). In addition, F‐NH2 treatment markedly reversed the HI induced hyperphosphorylation of p38 MAPK and NF/κB p65, with no obvious influence on their total protein expression (Figure ). Moreover, PAR‐2 inhibition mitigated microglial phagocytic activation, as evidenced by reduced CD68 expression, and partially restored the levels of synaptic structural proteins PSD95 and SYP (Figure ). Consistent with these molecular changes, 3D reconstruction analysis further confirmed that F‐NH2 treatment reduced both the quantity and volume of PSD95 puncta engulfed by Iba1+ microglia (Figure ). Collectively, these pharmacological results solidify that PAR‐2/MAPK/NF‐κB signaling is a crucial upstream pathway driving microglial activation and excessive synaptic engulfment following neonatal HI injury. Microglia‐Targeted F2rl1 Silencing Attenuates p38 MAPK/NF‐κB Signaling and Synaptic Engulfment To further clarify the cell specific function of microglial PAR‐2 (encoded by F2rl1) in mediating HI induced inflammatory signaling and pathological synaptic engulfment, we specifically knocked down microglial F2rl1 via stereotactic injection of AAV9‐CX3CR1‐shF2rl1, with AAV9‐CX3CR1‐shNC serving as the negative control (Figure ). Successful F2rl1 knockdown was verified by the markedly reduced F2rl1 mRNA level in the HI+shF2rl1 group relative to the HI + shNC group (Figure ). Consistent with the transcriptional suppression of F2rl1, microglial F2rl1 silencing significantly downregulated PAR‐2 protein expression and mitigated HI induced hyperphosphorylation of p38 MAPK and NF‐κB p65, while the total protein levels of p38 MAPK and NF‐κB p65 remained unchanged. In addition, F2rl1 knockdown efficiently reduced the expression of the phagocytic marker CD68 (Figure ). Moreover, the loss of synaptic proteins PSD95 and SYP following HI injury was partially rescued by microglial F2rl1 inhibition (Figure ). Consistently, 3D reconstruction analysis demonstrated a prominent reduction in the volume of PSD95 puncta internalized within Iba1+ microglia after F2rl1 silencing (Figure ). Taken together, these cell targeted knockdown results confirm that microglial PAR‐2 is a potential regulator of HI triggered p38 MAPK/NF‐κB signaling activation, CD68 dependent phagocytic phenotypic transformation, and excessive microglia mediated synaptic engulfment. Tryptase Related Signaling Contributes to PAR‐2/MAPK/NF‐κB Activation and Microglial Synaptic Engulfment Mast cell‐derived tryptase has been reported to interact with microglial PAR‐2 and trigger neuroinflammatory responses. To further determine whether tryptase acts as an upstream regulator of the PAR‐2/MAPK/NF‐κB cascade and mediates HI‐induced pathological synaptic pruning, we pharmacologically inhibited endogenous tryptase activity using the selective tryptase inhibitor APC366. Immunofluorescence analysis revealed that APC366 treatment effectively abolished the HI‐induced upregulation of PAR‐2 immunoreactivity and reduced the abundance of PAR‐2+/Iba1+ microglia (Figure ). Consistent with these phenotypic changes, Western blot results demonstrated that APC366 markedly decreased the protein levels of tryptase and PAR‐2 and suppressed the hyperphosphorylation of p38 MAPK and NF‐κB p65 following HI injury (Figure ). Moreover, tryptase inhibition reduced CD68 expression, restored the downregulated synaptic proteins PSD95 and SYP, and diminished the volume and abundance of PSD95 puncta engulfed by Iba1+ microglia (Figure ). Notably, neither APC366 nor F‐NH2 intervention altered the basal levels of PAR‐2, MAPK/NF‐κB signaling, CD68, PSD95, or SYP under sham conditions, excluding non‐specific effects of drug treatment (Figure ). In vitro OGD/R experiments using BV2 microglia further validated the regulatory axis between tryptase and PAR‐2 signaling. Tryptase stimulation markedly increased the expression of PAR‐2, CD68, and elevated the phosphorylation levels of p38 MAPK and NF‐κB p65 under OGD/R conditions, whereas pharmacological blockade of PAR‐2 with F‐NH2 efficiently reversed these tryptase‐mediated pro‐inflammatory and phagocytic alterations (Figure ). In contrast, the total protein levels of p38 MAPK and NF‐κB p65 showed no significant differences among these groups (Figure ). Collectively, these in vivo and in vitro findings demonstrate that mast cell‐derived tryptase serves as a critical upstream trigger for microglial PAR‐2 activation, which initiates downstream MAPK/NF‐κB signaling and ultimately drives excessive microglial synaptic engulfment after HI injury. APC366 Attenuates Synaptic Damage and Improves Long‐Term Cognitive Function After HI Insult Given the beneficial effects of tryptase inhibition on suppressing microglial overactivation and synaptic loss, we further explored whether APC366 could protect synaptic ultrastructure and rescue long‐term cognitive deficits following HI injury. Golgi staining analysis showed that HI injury markedly reduced dendritic complexity and spine density, while APC366 treatment significantly increased dendritic intersection numbers and spine density, restoring these morphological parameters to levels comparable to those in sham animals (Figure ). Consistent with the dendritic remodeling results, transmission electron microscopy (TEM) further confirmed synaptic structural protection by APC366. Compared with the vehicle‐treated HI group, APC366 intervention increased the number of presynaptic vesicles and elongated the postsynaptic density length, effectively ameliorating HI‐induced synaptic damage (Figure ). We subsequently evaluated long‐term cognitive function via the MWM and Y‐maze tests. During the MWM training phase, HI rats exhibited significantly prolonged escape latencies, indicating impaired spatial learning ability, whereas APC366 treatment substantially shortened escape latency and improved learning performance (Figure ). In the probe trial, APC366 treated HI rats displayed increased target platform crossings and prolonged residence time in the target quadrant, reflecting improved spatial memory retention (Figure ). No significant differences in swimming speed were observed across groups, ruling out the interference of motor function (Figure ). The Y‐maze test further verified the cognitive protective effects of APC366. HI induced deficits in novel arm exploration, including reduced novel arm entries and shorter exploration time, were significantly rescued by APC366 administration (Figure ). Taken together, these results demonstrate that tryptase inhibition by APC366 preserves hippocampal synaptic integrity and exerts long‐term protective effects on cognition after neonatal HI injury. Discussion This study identifies MC‐derived tryptase as a potential upstream trigger of excessive synaptic pruning after neonatal HI. HI insult increased hippocampal MC accumulation and tryptase production and further activated PAR‐2/p38 MAPK/NF‐κB signaling in microglia. This signaling activation was associated with C1q/C3‐dependent synaptic tagging and increased microglial engulfment of PSD95‐containing postsynaptic fragments. Microglia‐targeted F2rl1 silencing reduced pathway activation and synaptic engulfment, confirming the functional requirement of microglial PAR‐2 in this pathological cascade. Pharmacological blockade of either tryptase or PAR‐2 yielded comparable neuroprotective phenotypes. Moreover, tryptase inhibition attenuated synaptic damage and rescued long‐term cognitive impairments. These findings expand the classical view of mast cells as purely peripheral immune cells, demonstrating their capacity to modulate microglia‐dependent synaptic homeostasis within the injured neonatal brain. MC are increasingly recognized as resident innate immune cells that rapidly respond to injury and modulate neuroinflammatory processes, including changes in blood brain barrier integrity observed in various CNS disorders [, ]. Consistent with this role, hippocampal tryptase increased within 6 h after HI and remained elevated for up to 24 h, indicating that the tryptase response begins early and persists during the acute phase of injury. Increased c‐Kit and tryptase signals, together with a greater number of morphologically identified hippocampal MC, further linked this response to MC changes after HI. MC counts and tryptase levels were also associated with acute neurological deficits, suggesting that these early immune changes are related to the severity of neurological dysfunction. Together, the early time course, histological findings, and associations with neurological deficits support a role for MC‐derived tryptase in the early pathological response to neonatal HI. MC play a pivotal role as “pioneers” of the immune response during the initial stages of brain injury or inflammation by rapidly releasing mediators, such as tryptase and histamine, which activate microglia both directly and indirectly [, ]. Under physiological conditions, microglia eliminate redundant or dysfunctional synaptic connections through precise pruning, which is essential for synaptic development and plasticity [, , ]. However, in the pathological context of HI injury, we observed four features indicative of aberrant rather than developmental pruning. First, complement labeling was markedly increased, with neuron associated C1q and C3 signals far exceeding those observed during normal developmental pruning and indicating excessive complement associated synaptic tagging. Second, RNA analysis and immunostaining indicated an enhanced microglial phagocytic state and altered microglia–neuron communication after HI. Increased CD68 in Iba1+ microglia supported greater lysosomal and phagocytic activity. The rise in CX3CR1 signal reflected changes in CX3CL1–CX3CR1 mediated neuron–microglia communication during synaptic remodeling [, ]. Third, this phagocytic state was accompanied by a substantial increase in PSD95 positive material internalized within microglia, reflecting non‐selective engulfment rather than refinement of weak synapses. Finally, ultrastructural analysis revealed synaptic damage, including reduced presynaptic vesicles and shortened postsynaptic densities, consistent with synaptic loss rather than physiological remodeling. Collectively, these findings distinguish pathological pruning from homeostatic developmental remodeling and provide a mechanistic basis for the observed cognitive deficits following neonatal HI insult. PAR‐2 is a pivotal mediator of MC–microglia interactions. Unlike PAR‐1, PAR‐3, and PAR‐4, which are primarily activated by thrombin, PAR‐2 can be activated by mast cell tryptase [, , ]. In line with this, we observed PAR‐2 fluorescence and PAR‐2+/Iba1+ microglia increased markedly after HI. This pattern was reversed according to pharmacological blockade of PAR‐2 by F‐NH2. Compared with sham rats, F‐NH2 treatment attenuated microglial PAR‐2 upregulation and suppressed activation of the MAPK/NF‐κB pathway after HI. These data support a required role for PAR‐2 in HI‐induced activation of the MAPK/NF‐κB pathway. Consistent with this, F‐NH2 reduced CD68 expression, restored PSD95 and SYP levels, and microglial engulfment of PSD95. Microglia‐targeted F2rl1 silencing reproduced these effects, identifying microglial PAR‐2 as a key link between tryptase signaling and pathological synaptic engulfment. While microglia‐targeted F2rl1 silencing supports a key role for microglial PAR‐2 in HI‐associated synaptic engulfment, the effects of systemic pharmacological PAR‐2 inhibition may also involve PAR‐2 expressed by other CNS cell types. Unlike previous studies that have mainly linked PAR‐2 to neuroinflammation in neurodegenerative disorders [, , ], our findings extend its role to aberrant synaptic pruning in neonatal HI, thereby broadening its relevance in central nervous system injury. MC‐derived tryptase, an endogenous activator of PAR‐2, plays an important role in neuroinflammation. Previous studies have shown that tryptase activates PAR‐2 in microglia and astrocytes, promoting the release of pro‐inflammatory cytokines such as IL‐6 and TNF‐α [, ]. In a cardiac arrest‐induced global ischemia model, increased tryptase and PAR‐2 expression was associated with neurological deficits and hippocampal neuronal degeneration, whereas APC366 treatment exerted neuroprotective effects []. Consistent with these findings, APC366 reduced PAR‐2/p38 MAPK/NF‐κB signaling and microglial engulfment of PSD95 positive material after neonatal HI. Complementary BV‐2 experiments further showed that exogenous tryptase activated PAR‐2/p38 MAPK/NF‐κB signaling and increased CD68 expression under OGD/R conditions, whereas F‐NH2 attenuated these responses. These findings support a direct role for tryptase in activating PAR‐2‐dependent signaling in microglia. APC366 also preserved dendritic complexity, spine density, and synaptic ultrastructure. These structural benefits were accompanied by improved long‐term spatial learning and memory after HI. Together, these findings identify MC‐derived tryptase as an upstream driver of PAR‐2‐dependent synaptic injury and suggest that early inhibition of MC–microglia signaling may reduce long‐term neurological impairment after neonatal HI. This study has several limitations. We did not characterize the specific microglial subpopulation mediating this pathological cascade, nor did we explore whether this signaling axis operates comparably in the mature brain. In addition, although microglia‐targeted F2rl1 silencing strengthens causal inference, systemic pharmacological PAR‐2 inhibition cannot rule out contributions from other CNS cell types. Moreover, the study was not statistically powered to evaluate potential sex‐dependent effects. In conclusion, our present findings demonstrate that MC‐derived tryptase drives aberrant microglia‐mediated synaptic pruning in neonatal HIE. Microglial F2rl1 knockdown, as well as pharmacological inhibition of PAR‐2 or tryptase, reduced p38 MAPK/NF‐κB activation and excessive synaptic engulfment. Tryptase inhibition additionally maintained synaptic integrity and rescued cognitive performance. Early therapeutic targeting of MC‐microglia crosstalk may represent a promising strategy to limit long‐term neurological deficits following neonatal HI. Ethics Statement All animal experiments were approved by the Animal Care and Use Committee at Fujian Provincial Hospital (Fuzhou, China) (Approval No: IACUC‐FPH‐PZ‐20250304). Consent All the co‐authors and participants have given their consent for publication.